MDS' Q1 Revenues Drop 13 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – MDS today reported that its first-quarter revenues fell 13 percent year over year, with its MDS Analytical Technologies segment posting a 27 percent decline in revenues for the quarter.

The Toronto-based firm brought in total revenues of $257 million for the three-month period ended Jan. 31. It said that excluding the impact of foreign exchange, acquisitions, and divestitures, its revenues were down 1 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.